Cancer Patients on Chemotherapy Likely Not Fully Protected by COVID-19 Vaccine

vaccine
Monday, October 4, 2021

Cancer Center researchers found lower immune response to the COVID-19 vaccine in patients on active chemotherapy. A third dose of the Pfizer vaccine boosted immune response.

news.arizona.edu

Tags

BIO5
Cancer Center
College of Medicine - Tucson
COVID-19
COVID-19 vaccine
Experts
Exploration
New Economy Initiative
Research
Health

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now